HIV-related mortality among tuberculosis patients in the Netherlands, 1993-2001

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 9, 2007, Pages 1038-1041

  Haar, C H ^a,b   Cobelens, F G J ^a,c   Kalisvaart, N A ^a   Van Gerven, P J H J ^a   Van Der Have, J J ^b  

^a KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^b Municipal Health Service   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Human immunodeficiency virus; Low prevalence; Mortality; The Netherlands; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; NEWBORN; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; STANDARD; TUBERCULOSIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; FEMALE; HIV; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; RISK FACTORS; TUBERCULOSIS;

EID: 34548784963     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Churchyard G J, Kleinschmidt I, Corbett E L, Murray J, Smit J, De Cock K M. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4: 705-712.
2. Lawn S D, Acheampong J W. Pulmonary tuberculosis in adults: factors associated with mortality at a Ghanaian teaching hospital. West Afr J Med 1999; 18: 270-274.
3. Whalen C, Horsburgh C R, Horn D, Lahar C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
4. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064.
5. Dheda K, Lampe F C, Johnson M A, Lipman M C. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190: 1670-1676.
6. Haar C H, Cobelens F G, Kalisvaart N A, Van der Have J J, Van Gerven P J, Van Deutekom H. HIV prevalence among tuberculosis patients in The Netherlands, 1993-2001: trends and risk factors. Int J Tuberc Lung Dis 2006; 10: 768-774.
7. Rieder H L. Epidemiologic basis of tuberculosis control. Paris, France: International Union Against Tuberculosis and Lung Disease, 1999.